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Background: Retroviral integration favors weakly conserved palindrome sequences at the sites of viral DNA joining
and generates a short (4–6 bp) duplication of host DNA flanking the provirus. We previously determined two key
parameters that underlie the target DNA preference for prototype foamy virus (PFV) and human immunodeficiency
virus type 1 (HIV-1) integration: flexible pyrimidine (Y)/purine (R) dinucleotide steps at the centers of the integration
sites, and base contacts with specific integrase residues, such as Ala188 in PFV integrase and Ser119 in HIV-1 integrase.
Here we examined the dinucleotide preference profiles of a range of retroviruses and correlated these findings with
respect to length of target site duplication (TSD).
Results: Integration datasets covering six viral genera and the three lengths of TSD were accessed from the literature
or generated in this work. All viruses exhibited significant enrichments of flexible YR and/or selection against rigid RY
dinucleotide steps at the centers of integration sites, and the magnitude of this enrichment inversely correlated with
TSD length. The DNA sequence environments of in vivo-generated HIV-1 and PFV sites were consistent with integration
into nucleosomes, however, the local sequence preferences were largely independent of target DNA chromatinization.
Integration sites derived from cells infected with the gammaretrovirus reticuloendotheliosis virus strain A (Rev-A),
which yields a 5 bp TSD, revealed the targeting of global chromatin features most similar to those of Moloney
murine leukemia virus, which yields a 4 bp duplication. In vitro assays revealed that Rev-A integrase interacts with
and is catalytically stimulated by cellular bromodomain containing 4 protein.
Conclusions: Retroviral integrases have likely evolved to bend target DNA to fit scissile phosphodiester bonds
into two active sites for integration, and viruses that cut target DNA with a 6 bp stagger may not need to bend
DNA as sharply as viruses that cleave with 4 bp or 5 bp staggers. For PFV and HIV-1, the selection of signature
bases and central flexibility at sites of integration is largely independent of chromatin structure. Furthermore,
global Rev-A integration is likely directed to chromatin features by bromodomain and extraterminal domain proteins.
Keywords: Retrovirus, Integrase, DNA flexibility, Dinucleotide steps, Integration sites, Nucleosomes, BET proteinsBackground
The integration of a DNA copy of the viral RNA gen-
ome into a host cell chromosome is a critical step in
the retroviral lifecycle. Retroviruses accordingly encode
for an integrase (IN) enzyme, which is a specialized
DNA recombinase. Integration begins with the formation
of the intasome nucleoprotein complex, which consists of
an IN tetramer assembled on the ends of the linear viral
DNA (vDNA) [1-3]. The two inner subunits of the tetra-
mer cleave the vDNA ends adjacent to invariant 5′-CA-3′* Correspondence: alan_engelman@dfci.harvard.edu
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unless otherwise stated.dinucleotides to yield reactive CAOH-3′ hydroxyl groups
[3-8]. The intasome is transported from the cytoplasm to
the nucleus as part of a large assembly of viral and host
proteins known as the preintegration complex [9-11]. In
the nucleus the intasome engages host cell chromatin to
form the target capture complex (TCC) [3,12]. The inner
subunits of the IN tetramer utilize the vDNA CAOH-3′
termini to cleave both strands of the target DNA (tDNA)
in a staggered fashion, at the same time joining the vDNA
ends to tDNA 5′-phosphates [13]. The resulting DNA re-
combination intermediate contains free vDNA 5′ ends
abutting single stranded gaps in the tDNA, which vary in
length from four to six nucleotides, depending on the
retrovirus [14-17]. The single-stranded gaps are repairedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(TSD) of 4–6 bp flanking the provirus.
Several features of the animal cell genome, from the
tDNA sequence at the site of integration to higher-order
chromatin structure, can influence the selection of retro-
viral integration sites (see [18] for a recent review). Seven
different genera, alpha through epsilon, lenti, and spuma,
comprise the Retroviridae family, and preferential target-
ing of structural chromatin features is most evident for
the lenti- and gammaretroviruses. Lentiviruses preferen-
tially integrate along the bodies of actively transcribed
genes [19], whereas the gammaretroviruses favor tran-
scriptional start sites (TSSs) and active enhancer regions
[20-22]. These preferences are in large part governed
by interactions between IN proteins and cognate cellu-
lar factors [18]. The lentiviral IN-binding protein lens
epithelium-derived growth factor (LEDGF)/p75 directs
integration to active genes [23-26], whereas bromodo-
main and extraterminal domain (BET) proteins BRD2, 3,
and 4 interact with Moloney murine leukemia virus
(MoMLV) IN to affect TSS-proximal integration [27-29].
Viruses from the other profiled genera – integration site
preferences of epsilonretroviruses have not been reported –
show less propensity to target chromatin-specific features
than do either the lentiviruses or gammaretroviruses, with
the betaretrovirus mouse mammary tumor virus (MMTV)
displaying the least selectivity of all [30].
Analyses of retroviral integration sites revealed weak
palindromic tDNA sequence consensuses at the sites of
vDNA joining [14-17,31]. A palindromic consensus im-
plies dyadic symmetry within the IN nucleoprotein com-
plex that engages tDNA, and crystallographic analysis
of the prototype foamy virus (PFV) TCC revealed key
features of the inner IN dimer within the tetramer that
dictate the selection of the consensus PFV integration
site (−3)KWK\VYRBMWM(+6) (written using Inter-
national Union of Biochemistry base codes; the back-
slash indicates the position of vDNA plus-strand
joining, and the italics mark the TSD, which is 4 bp for
PFV) [12]. The tDNA is accommodated in a severely
bent conformation, with the major groove widened
such that the dinucleotide at the center of the integra-
tion site (YR) is unstacked. Given the relatively weak
nature of nucleotide specificity at integration sites, it
was not surprising that a number of IN main chain
amide groups interacted with the tDNA backbone in
the TCC structure. In addition, base specific contacts
were observed for PFV IN residues Ala188, which resides
in the catalytic core domain (CCD), and Arg329, which is
part of the IN C-terminal domain. Ala188 in particular
interacted with bases that lay 3 positions upstream from
the points of vDNA joining, whereas Arg329 interacted
with bases at either edge of the integration site, as well as
those at symmetric nucleotide positions −2 and +5 [12].The variety of dinucleotide steps differ in their propensity
to support distortion of a DNA double helix, which reflects
their inherent base stacking interactions [32]. Pyrimidine-
purine (YR) and RY steps are the most and least distortable,
respectively, whereas YY and RR display an intermediary
level of flexibility. The strongly preferred YR at the center
of PFV integration sites accommodates the sharp tDNA
bend required for integration. The consensus target site
sequence (−3)TDG\(G/V)TWA(C/B)CHA(+7) for hu-
man immunodeficiency virus type 1 (HIV-1) was subse-
quently shown to harbor the dinucleotide signature
motif (0)RYXRY(+4), which selects against rigid RY di-
nucleotides at the center of integration sites (due to the
odd number of bp between the sites of HIV-1 DNA
joining, the location of the integration site center en-
compasses two overlapping positions: nucleotides +1
and +2 and nucleotides +2 and +3) [33].
Inherent curvature or bendability of DNA substrates
positively correlates with frequency of integration tar-
geting [34-36], and tDNA deformed by the binding of
nucleosomes [37-39] or other DNA bending proteins
[34,40] can be utilized preferentially by IN over naked
DNA in vitro. Nucleosomes are favored sites for inte-
gration during MoMLV and HIV-1 infection [41-45].
Moreover, A/T-rich sequences that emanate outward
from the central, local palindrome at the sites of vDNA
insertion exhibit periodicity coincident with the
outward-facing major grooves on the nucleosome sur-
face [34,37,38,42-44]. However, because PFV [46] and
HIV-1 [33] integration in vivo and using naked plasmid
tDNA substrates in vitro generated similar palindrome
signatures, the forces that govern the selection of par-
ticular bases at the sites of integration appear for the
most part independent of tDNA chromatinization.
In this study we extended dinucleotide step analysis of
retroviral integration sites to a total of 12 viruses. We find
that central flexibility is a conserved feature and that it in-
versely correlates with the length of TSD. By comparing in-
tegration sites in naked plasmid or cellular tDNA to those
generated during PFV and HIV-1 infection, we confirm
that central flexibility and local nucleotide preferences are
for the most part independent of nucleosome content. Fur-
thermore, we report the integration site preferences of reti-
culoendotheliosis virus strain A (Rev-A) in infected cells,
which paralleled those of previously reported gammaretro-
viruses despite the fact that Rev-A integration generates a
5 bp duplication of tDNA. Thus, Rev-A integration distri-
bution mirrored that of MoMLV, and we accordingly show
that Rev-A IN interacts with and is catalytically stimulated
by a portion of the MoMLV integration host cofactor
BRD4 that contains the IN-interacting extraterminal (ET)
domain. Akin to MoMLV [27-29], IN binding to BET pro-
teins likely directs Rev-A integration to chromatin features
such as TSSs.
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Analytic strategy
In light of the similarity in the selection for central flexi-
bility at sites of PFV and HIV-1 integration, we extended
dinucleotide frequency analyses to a total of 12 retrovi-
ruses. Considering that retroviral TSDs vary from 4 to 6
bp, we analyzed four viruses that generate 4 bp duplica-
tions, four that generate 5 bp duplications, and four that
generate 6 bp duplications. Viruses from two to three
different genera comprise each of these subsets (Table 1).
Four bp TSDs are yielded by the spumavirus PFV
[47,48] as well as the gammaretroviruses MoMLV
[49,50], porcine endogenous retrovirus (PERV) [51,52],
and xenotropic murine leukemia virus-related virus
(XMRV) [53,54]. The alpharetrovirus avian sarcoma-
leukosis virus (ASLV) [55,56], deltaretrovirus human T-
lymphotropic virus type 1 (HTLV-1) [57,58], and betare-
troviruses human endogenous retrovirus K family
(HERV-K) [59] and MMTV [60] yield 6 bp TSDs. In
addition to HIV-1 [61,62], the lentiviruses simian im-
munodeficiency virus (SIV) [63] and equine infectious
anemia virus (EIAV) [64], as well as the gammaretro-
virus Rev-A [65,66], yield 5 bp TSDs.
Perusal of the literature revealed that the number of
reported integration site datasets from virus-infected
cells ranged from a small handful for Rev-A [65] to sev-
eral million for MoMLV [21,22]. Rev-A is of particular
interest, as it is a gammaretrovirus with a 5 bp TSD; all
other gammaretroviruses yield 4 bp TSDs [14,15,17]. We
accordingly initiated this study by determining the se-
quences of 834 unique integration sites from HEK293T
cells infected with a Rev-A viral vector by ligation-
mediated PCR. The targeting preferences of Rev-A for
genomic annotations such as genes, TSSs, CpG islands,
and gene density are described toward the end of the Re-
sults section. As the HEK293T DNA was fragmented byTable 1 Retroviruses included in this study
Virus (genus) TSD (bp) Reference(s) Number of sequencesa
PFV (spuma) 4 [92,93] 2,924
MoMLV (gamma) 4 [44] 53,463
PERV (gamma) 4 [94] 1,668
XMRV (gamma) 4 [44,53] 5,487
EIAV (lenti) 5 [24,64] 1,172
HIV-1 (lenti) 5 [87] 335,968
Rev-A (gamma) 5 This study 834
SIV (lenti) 5 [95,96] 168
ASLV (alpha) 6 [97-99] 916
HERV-K (beta) 6 [100] 1,071
HTLV-1 (delta) 6 [17,101,102] 6,820
MMTV (beta) 6 [103] 178,574
aAll sequences derived from virus-infected cells.digestion with restriction endonucleases AvrII, NheI,
and SpeI, a matched random control (MRC) of 282,824
unique sites was produced by selecting random positions
in proximity of these restriction sites in human genome
build 19 (hg19). Sequences extracted from GenBank
(http://www.ncbi.nlm.nih.gov/genbank/) or obtained from
the authors of prior studies yielded datasets for the
remaining 11 viruses that encompassed from ~170 to
336,000 unique integration sites (Table 1).
Sequence logos [67] were compiled to provide a
visualization of base preferences at each nucleotide pos-
ition at and surrounding the points of vDNA joining for
the 12 different viruses (see Figures 1, 2 and 3, A-D).
The position of vDNA insertion on the tDNA plus
strand by convention was designated as 0, with upstream
and downstream nucleotide positions extending in the
negative and positive directions, respectively. As the most
significant retroviral tDNA base preferences exist within
and closely adjacent to the TSD [42] (the boundaries of
which are marked by blue arrows in the sequence logos),
we initially limited our analysis to base positions −5
through +9, or a total of 15 nucleotides. The statistical sig-
nificance of nucleotide frequencies for each virus at each
tDNA base position, which was compared to the MRC
that was generated for the Rev-A integration site analysis,
is presented in Additional file 1: Figure S1. These frequen-
cies were calculated as observed-to-expected ratios and
were thus normalized for human genomic DNA G/C
content. The sequence logos by contrast should be pri-
marily considered as visual aids because they depict
raw base frequencies without normalization. The vast
majority of positions within the 15 base windows dis-
played statistically significant variance from random across
the viral integration sites (Additional file 1: Figure S1). For
the dinucleotide step analysis, successive nucleotide posi-
tions were binned into groups of two; dinucleotide bin
numbers are annotated below the sequence logo x-axes in
Figures 1, 2 and 3, panels A-D. The frequencies of YR and
RY dinucleotide usage at each bin position were compared
to random frequencies using Fisher’s exact test (Additional
file 2: Figure S2).
Dinucleotide step analysis of viral integration sites with 4
bp TSDs
Symmetric base preferences project outward from the
center of retroviral integration sites [14-17]. By conven-
tion, the center of an integration site with a 4 bp TSD is
designated between nucleotide positions +1 and +2, which
coincides with dinucleotide bin position +1 (Figure 1, ver-
tical dotted line). As expected, PFV integration selected
for flexible YR dinucleotides at this position [12] (Figure 1E
and Additional file 2: Figure S2A). Perusal of the sequence
logos indicated unique nucleotide signatures across the
integration sites of viruses that generate 4 bp TSDs
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Figure 1 Sequence logos and dinucleotide step analysis of integration sites with 4 bp TSDs. (A-D) The height of each individual base at a given
position is proportional to the frequency of the corresponding nucleotide within the sequences represented by the logos, and the height of each
stack of base logos reflects the level of conservation at that position. (E) Percent YR utilization across the integration sites from panels A-D is shown
relative to the calculated random value of 22% (dotted gray horizontal line). (F) Same as in panel E, except that the graph depicts RY utilization across
the integration sites. Statistical analysis of panel E and F results are shown in Additional file 2: Figure S2 panels A and B, respectively. (G and H) The
percent of YR (panel G) and RY (panel H) enrichment for each virus compared to random.
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nucleotide and dinucleotide content were evident
across these sites. Within the TSD, thymidine and adeno-
sine were disfavored at symmetric positions 0 and +3, re-
spectively. By contrast, outside of the TSD window Tand A
were preferred at symmetric positions −2 and +5, respect-
ively (Additional file 1: Figure S1). Moreover, there was
strong consensus for YR selectivity at the central dinucleo-
tide step (Figure 1E and Additional file 2: Figure S2A). The
calculated random frequency of YR dinucleotide occur-
rence in the human genome is 22% (Figure 1E, grey dashed
horizontal line). YR utilization at bin position +1 by PFV,
MoMLV, PERV, and XMRV were on average increased by
63% relative to this value (Figure 1G), equating to highly
significant differences (P values ranging from 5 x 10−21for PERV to >2.2 x 10−308 for MoMLV; Additional file 2:
Figure S2A). On the contrary, all four viruses displayed
strong selection against central RY steps, with an average
value depressed by 43% relative to the expected value
(Figure 1F, H, and Additional file 2: Figure S2B; P values
of 1.9 x 10−27 for PERV to >2.2 x 10−308 for MoMLV).
Dinucleotide step analysis of viruses that yield 5 bp TSDs
Because viruses like HIV-1 join their vDNA ends across
an odd number of tDNA bp, the center of their integra-
tion sites falls squarely on nucleotide position +2, which
is a common element of dinucleotide bins +1 and +2
(Figure 2A-D). As recently elucidated the consensus se-
quence (0)RYXRY(+4), which resides at the center of
HIV-1 integration sites [33], ensures for either YR or YY
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Figure 2 Sequence logos and dinucleotide step analysis of integration sites from retroviruses that yield 5 bp TSDs. Sequence logos for HIV-1 (A),
EIAV (B), SIV (C), and Rev-A (D). (E) YR step analysis for the integration sites depicted in panels A-D. (F) Same as in panel E, except RY dinucleo-
tide frequencies were calculated. Statistical analyses of panel E and F results are depicted in Additional file 2: Figure S2 panels C and D, respect-
ively. Percent YR and RY enrichment for each virus compared to random is shown in (G) and (H), respectively. Other labeling is as in Figure 1.
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nucleotide positions +2 and +3. Therefore, HIV-1 on
average selects for a flexible YR step at one of the two
central dinucleotide positions while strongly selecting
against rigid RY steps. The tDNA sequences surrounding
the integration sites of viruses that yield 5 bp TSDs were
generally dissimilar from one another (Figure 2A-D).
However, as was the case for the viruses that yield 4 bp
TSDs, commonalities were evident among the sites that
harbor 5 bp TSDs. HIV-1, EIAV, SIV, and Rev-A signifi-
cantly disfavored T/A bases at the positions that delin-
eate the external boundaries of the TSD, which in this
case is positions 0 and +4, respectively (Additional file 1:
Figure S1). All four viruses also displayed the preferencefor (0)RYXRY(+4) at the duplicated region and the
symmetric preference for T/A adjacent to the TSD that
was exhibited by 4-bp duplicating viruses. The posi-
tioning of this preference relative to the TSD window
however varied among this set of viruses, falling two
bases exterior to the TSD for SIV and Rev-A but three
bases exterior for HIV-1 and EIAV (Additional file 1:
Figure S1; Figure 2A-D).
Perhaps reflecting the fact that the center of these in-
tegration sites is spread over two dinucleotides, variable
preference for YR/RY selectivity was apparent at the
two central positions. At dinucleotide bin position +1,
EIAV, HIV-1, and Rev-A each exhibited a similar en-
richment for YR utilization, with an average relative
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Figure 3 Sequence logos and YR/RY dinucleotide selectivities of viral integration sites with 6 bp TSDs. Sequence logos are shown for conglomerate
integration sites of ASLV (A), HERV-K (B), HTLV-1 (C), and MMTV (D). (E) YR frequency utilization across the integration sites of viruses depicted in panels
A-D. (F) Same as in panel E, except the plot is for RY dinucleotide utilization. Statistical analyses of panel E and F results are shown in Additional file 2:
Figure S2 panels E and F, respectively. The percent YR and RY enrichment for each virus compared to random is in (G) and (H), respectively. Other
labeling is as in Figure 1.
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and Additional file 2: Figure S2C; P values from 5 x 10−3
for Rev-A to >2.2 x 10−308 for HIV-1). Although SIV also
trended toward YR enrichment at bin position +1, this
increase was not statistically different from random
(Additional file 2: Figure S2C, P = 0.46). As reported [33],
the enrichment for YR utilization at bin position +2 by
HIV-1 was statistically significant (Figure 2E, G, and
Additional file 2: Figure S2C; P >2.2 x 10−308). While EIAV
and SIV also trended toward YR enrichment at bin
position +2, the difference only achieved statistical sig-
nificance for SIV (P = 0.02). Rev-A by contrast did not
exhibit YR enrichment at dinucleotide bin position +2. In
terms of RY selectivity (Figure 2F, H, and Additional file 2:
Figure S2D), EIAV and HIV-1 similarly avoided the rigidstep at bin positions +1 and +2, averaging ~20% decreases
from random (Additional file 2: Figure S2D, P values ran-
ging from 5 x 10−4 for EIAV at bin position +2 to >2.2 x
10−308 for HIV-1 at both positions). While trending to-
ward selection against RY at both dinucleotide positions,
Rev-A registered as statistically different from random
only at position +1 (P = 10−6) while SIV registered as
different only at position +2 (P = 0.002).
Dinucleotide step analysis of viral integration sites with 6
bp TSDs
The center of the integration site for viruses that yield
6 bp TSDs lies between nucleotide positions +2 and +3,
which coincides with dinucleotide bin position +2
(Figure 3A-D). These integration sites on average yielded
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the viruses that create 4 bp and 5 bp TSDs (compare
Figure 3 to Figures 1 and 2). As with the previously dis-
cussed integration sites, T/A tended to be disfavored at the
inner edges of the TSD window, though this was more evi-
dent for the sites generated by ASLV, HERV-K, and HTLV-
1 than it was for MMTV (Additional file 1: Figure S1).
ASLV, HERV-K, and HTLV-1 also revealed preference for
T/A outside of the TSD window, two bases removed from
the window for HERV-K and HTLV-1 but three bases
removed for ASLV (Additional file 1: Figure S1),
All four viruses exhibited a significant enrichment for
YR utilization at the center of their integration sites
(Figure 3E, G, and Additional file 2: Figure S2E; P values
ranged from 0.02 for HERV-K to 1.1 x 10−15 for HTLV-1).
The selection against RY utilization at dinucleotide bin
position +2 by these viruses was also significant (Figure 3F,
H), yielding P values that ranged from 3.2 x 10−4 for
HERV-K to 8.9 x 10−110 for MMTV (Additional file 2:
Figure S2F).
Target DNA base preferences and central flexibility are
determined by IN independent of nucleosome content
Integration sites on nucleosomal tDNA map to positions
of DNA major groove distortion in vitro [35,37-39] and
during virus infection [41-44]. Prior work with PFV [46]
and HIV-1 [33] revealed that similar bases were selected
in cells and when using the respective purified IN pro-
tein with naked tDNA in vitro, implying that nucleo-
some structure may not grossly influence the selection
of tDNA bases at the sites of vDNA joining. However,
the naked tDNA used in these studies was supercoiled
plasmid with relatively low sequence diversity and little-
to-no capacity to position native nucleosomes. There-
fore, we accessed a panel of 22,117 unique integration
sites from a reaction that utilized recombinant PFV inta-
somes and deproteinized human DNA [39], which
served as an optimally diverse, nucleosome-free tDNA
substrate.
The window of sequence logo analysis was extended
from 15 bp (Figures 1, 2 and 3) to 50 bp (Figure 4) to as-
sess signature tDNA sequences preferentially bound by
nucleosomes, which show on average a 10.6 bp periodicity
for A/T-rich sequences [68] (Figure 4A). Comparing inte-
gration sites derived from PFV infected cells (Figure 4B)
to those generated in vitro with deproteinized cellular
DNA (Figure 4C) confirmed that the preference for local
tDNA sequences at the sites of virus insertion were in
large part generated independent of nucleosome content.
Re-analyzing 122 previously-reported in vitro concerted
integration events [33] to sites derived from virus infected
cells (Table 1) recapitulated the finding that the preference
for local tDNA sequence at the sites of HIV-1 integration
was independent of nucleosome content (Figure 4D, E).Both PFV and HIV-1 cell-based datasets exhibited cyc-
lical A/T-rich sequences that extended symmetrically
outward from the TSD with approximate 10 bp periodicity
(Figure 4B, D), as described previously for HIV-1 [42].
These cyclical base preferences, which were absent from
in vitro datasets (Figure 4C, E), and reminiscent of the A/
T-rich periodicity exhibited by nucleosome-bound DNA
(Figure 4A), indicated that PFV and HIV-1 IN select for
their preferred local tDNA sequences in the context of nu-
cleosomal DNA during virus infection [41,42] (Figure 4).
PFV and HIV-1 selected for marginally distinguishable
flexibility profiles at integration sites in naked tDNA
in vitro versus cellular DNA (Figure 5). As discussed
above, raw frequencies of YR enrichment and RY avoid-
ance for PFV at dinucleotide +1 equated to 39% and
13%, respectively (Figure 5A, B, blue curves). These
values corresponded to a 77% increase in YR utilization
and a 41% decrease in RY utilization relative to the
MRC values (Figure 5C, D). The bias for YR utilization
and against RY utilization at the center of integration
sites was marginally greater when using recombinant
PFV IN and naked cellular DNA than they were for
virus-infected cells. Specifically, IN selected for YR and
RY frequencies of 43% and 12% (Figure 5A, B), equating
to a 95% increase and a 45% decrease from random, re-
spectively (Figure 5C, D). These same trends also applied
to HIV-1. Raw YR frequencies at central bins +1 and +2
were 27%/27% for virus and 32%/32% for recombinant IN
protein (Figure 5E), and RY frequencies were 18%/18% for
virus and 14%/14% for recombinant IN (Figure 5F). Com-
paring these raw frequencies to the MRC, YR was
enriched by 23%/23% for virus and 45%/45% for recom-
binant IN, while RY was avoided by 18%/18% for virus
and 36%/36% for recombinant IN (Figure 5G, H).
Genomic distribution of retroviral integration sites
Using various parameters linked to integration that in-
clude IN amino acid sequence, targeting of cellular chro-
matin features, and length of TSD, prior studies have
phylogenetically linked subgroups of retroviral genera
together [17,64]. We recently questioned the general ap-
plicability of this approach, as MoMLV and Rev-A,
which are both gammaretroviruses, display similar tDNA
base preferences but yield 4 and 5 bp TSDs, respectively
[66]. It was therefore of interest to test if Rev-A integra-
tion distribution in cellular chromatin resembled that of
MoMLV and/or other retroviruses. We accordingly
mapped all of the integration sites used in this study,
which included 834 unique sites from Rev-A-infected
cells, with respect to several genomic annotations in-
cluding RefSeq genes, CpG islands, TSSs, and gene dens-
ity (Table 2). The statistical relevance of observed
frequencies versus the MRC were determined by Fisher’s
exact test for RefSeq genes, CpG islands, and TSSs and
AB
C
D
E
Chicken nucleosomal DNA
PFV, cellular chromatin
PFV, naked tDNA
HIV-1, cellular chromatin
HIV-1, naked tDNA
Figure 4 Sequence logos for PFV and HIV-1 integration sites in nucleosome-free versus chromatinized tDNA. (A) The logo illustrates the
average nucleotide sequence of the first 50 nucleotides of center-aligned nucleosomal DNA sequences isolated from chicken erythrocytes
[68]. (B) PFV integration sites derived from virus-infected cells [92,93]. (C) Integration sites from recombinant PFV intasomes and deproteinized
cellular DNA. (D) HIV-1 integration sites from virus-infected cells [87]. (E) Concerted HIV-1 integration sites from recombinant HIV-1 IN and
naked pGEM9Zf(−) plasmid DNA [33].
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listed in Additional file 3: Table S1).
The results of our analyses of 11 previously profiled
retroviruses are in line with those of the prior reports
(see Table 1 for the list of references). Distributions rela-
tive to CpG islands and TSSs were calculated by count-
ing sites that fell within a 5 kb window (+/− 2.5 kb) of
these features, while average gene density was calculated
by counting the number of RefSeq genes falling within a
1 Mb window (+/− 500 kb) of each integration site, and
then averaging this value for the entire dataset. Our
MRC dataset revealed that 45.7% of human DNA com-
prised RefSeq genes (Table 2). Most of the viruses tar-
geted RefSeq genes more frequently than this baseline
value, with HIV-1 and SIV displaying the greatest levelsof gene targeting (Table 2 and Additional file 3: Table S1).
PFV and MMTV by contrast avoided this annotation,
accomplishing only about 40% of their integrations within
RefSeq genes (P = 7.06 × 10−09 for PFV and 3.51 × 10−282
for MMTV). MMTV also avoided CpG islands (P = 9.94 ×
10−21) and TSSs (P = 7.66 × 10−62). All other viruses ex-
hibited increased targeting of these genomic features over
random, with the gammaretroviruses achieving the great-
est levels. Over 40% of PERV integration sites mapped in
the vicinity of a CpG island or a TSS (P > 2.2 × 10−308 for
both comparisons to random). The average gene density
surrounding MMTV integration sites (8.3 genes per Mb)
was lower than the MRC value of 9.2 (P > 2.2 × 10−308)
while all other viruses on average landed in regions that
contained more genes per Mb than random. The average
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Figure 5 Flexibility profiles for PFV and HIV-1 integration sites in nucleosome-free versus chromatinized tDNA. (A and B) YR and RY frequency
charts, respectively, for PFV integration sites into deproteinized genomic DNA (PFV in vitro) and from virus infection. Vertical dotted black line
represents central dinucleotide step(s), and horizontal dotted grey line represents the MRC frequency of YR/RY utilization. (C and D)) Bar graphs
illustrating the percent YR and RY enrichment, respectively, at the central dinucleotide step relative to MRC values. (E and F) YR and RY frequency
charts, respectively, for HIV-1 integration sites into naked plasmid DNA (HIV-1 in vitro) and from virus infection. (G and H) Bar graphs illustrating
the percent YR and RY enrichment, respectively, at the central dinucleotide steps compared to MRC.
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genes/Mb, respectively, were only marginally greater than
random (P = 3.33 × 10−40 and 2.95 × 10−24, respectively),
while the 23.4 genes/Mb value selected by PERV was the
greatest among the viruses analyzed (P > 2.2 × 10−308). As
expected, the ability for PFV IN to target chromatin-
specific features during integration was decreased signifi-
cantly when the reaction was conducted with deproteinized
cellular tDNA in vitro (Table 2; P values tabulated in
Additional file 4: Figure S3).
Rev-A integrated within RefSeq genes at a frequency
of 55.2%, which was significantly more frequent than the
MRC value of 45.7% yet less frequent than the HIV-1
value of 74.6% (Table 2 and Additional file 5: Figure S4;P = 5.22 × 10−8 and 9.08 × 10−34, respectively). Notably,
this frequency was not significantly different from the
other analyzed gammaretroviruses (P value range of 0.14
for MoMLV to 0.67 for PERV). The frequencies at which
Rev-A and MoMLV targeted CpG islands were also sta-
tistically indistinguishable (25.9% vs. 28.4%, respectively;
P = 0.12), yet were significantly different from the MRC
value of 4.6% as well as the HIV-1 frequency of 5.6%
(Table 2, Additional file 5: Figure S4). Approximately
25.9% of Rev-A integrations occurred within the 5 kb
windows surrounding TSSs, a result that was again sta-
tistically indistinguishable from the MoMLV value of
27.8% (P = 0.23). The frequencies at which XMRV and
PERV targeted CpG islands and TSSs were unique
Table 2 Genomic distribution of retroviral integration sites
Library Unique sites Within Refseq genes (%) Within 5 kb (+/− 2.5 kb)
of CpG (%)
Within 5 kb (+/− 2.5 kb)
of TSS (%)
Average gene density per Mb
(+/− 0.5 Mb) of integration sites
PFV 2,924 1,180 (40.4) 450 (15.4) 425 (14.5) 10.8
PFV (in vitro) 22,117 10,506 (47.5) 1,349 (6.1) 1,150 (5.2) 10.3
MoMLV 53,463 30,865 (57.7) 15,157 (28.4) 14,870 (27.8) 15.4
PERV 1,668 936 (56.1) 811 (48.6) 676 (40.5) 23.4
XMRV 5,487 3,086 (56.2) 1,022 (18.6) 1,100 (20.1) 14.5
EIAV 1,172 689 (58.8) 70 (6.0) 69 (5.9) 12.1
HIV-1 335,968 250,552 (74.6) 18,871 (5.6) 13,882 (4.1) 19.9
Rev-A 834 460 (55.2) 216 (25.9) 216 (25.9) 15.7
SIV 168 142 (84.5) 4 (2.4) 3 (1.8) 17.8
ASLV 916 320 (54.7) 55 (9.4) 44 (7.5) 11.3
HERV-K 1,071 541 (50.5) 131 (12.2) 108 (10.1) 17.8
HTLV-1 6,820 3148 (49.8) 523 (8.3) 467 (7.4) 10.7
MMTV 178,574 72,035 (40.3) 7,131 (4.0) 6,957 (3.9) 8.3
MRC 282,824 129,287 (45.7) 12,914 (4.6) 13,942 (4.9) 9.2
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Rev-A (Table 2, Additional file 5: Figure S4). Rev-A,
MoMLV, and XMRV integrated into similarly gene-
dense regions of chromatin, whereas the 23.4 gene/Mb
value displayed by PERV was more similar to the 19.9
gene/Mb value exhibited by HIV-1 (Table 2, Additional
file 5: Figure S4).
Rev-A IN interacts with and is catalytically stimulated by
the BRD4 ET domain in vitro
The interaction between MoMLV IN and BET proteins
(BRD2-4) in large part determines the promoter-proximal
integration profile of this virus [27-29]. The amino acid se-
quence of the IN C-terminal region, WxϕxxpxxPLbϕbϕR
(x, non-conserved position; ϕ, small hydrophobic; p, small
polar; b, basic), which dictates binding to BET proteins
[29,69,70], is a conserved feature of gammaretroviral IN
proteins including Rev-A IN [18]. The BET proteins com-
prise well-characterized bromodomain (BD) I and II and
the ET domain, the latter of which accounts for IN bind-
ing (Figure 6A) [27-29,68]. To test if BET proteins interact
with Rev-A IN, we expressed and purified hexahistidine-
tagged IN and the C-terminal fragment of BRD4462–720
that contains the ET domain (Figure 6A). As a control, we
substituted glutamic acid for conserved residue Leu-630;
the analogous L662E amino acid substitution in BRD2 ne-
gated binding to both MoMLV and feline leukemia virus
IN proteins in vitro [28].
Utilizing a nickel-nitrilotriacetic acid (Ni-NTA) pull
down format, Rev-A IN recovered input BRD4462–720
protein from the solution but failed to bind detectable
levels of BRD4462–720/L630E (Figure 6B). The BET pro-
teins as well as their isolated ET domains can stimulatethe concerted integration activity of MoMLV IN in vitro
[27,28,70]. We accordingly assessed the ability of Rev-A
IN to insert oligonucleotide vDNA substrates into super-
coiled plasmid tDNA in the presence of BRD4462–720 or
BRD4462–720/L630E. Two major types of integration prod-
ucts were expected under these reaction conditions
[1,2,46,66]: the integration of one vDNA end molecule
into one strand of plasmid DNA yields a tagged circle
that co-migrates with nicked plasmid molecules in an
agarose gel whereas the concerted integration of two
vDNA ends yields a population of products that migrate
as linearized plasmid molecules. As expected [66], Rev-A
IN catalyzed a low level of single vDNA end and concerted
integration activity in the absence of added BET protein
(Figure 7A, compare lane 2 to lane 1). BRD4462–720 stimu-
lated IN concerted integration activity in a dose dependent
manner, with an approximate fivefold boost in catalysis in
the presence of 0.5 μM protein (Figure 7B; P < 0.01). On
the contrary BRD4462–720/L630E did not appreciably stimu-
late Rev-A IN activity, even at the highest concentration
tested (Figure 7).
Discussion
Different aspects of the nuclear environment, from global
chromatin structure to local tDNA sequence, can influence
where retroviruses integrate [18]. Prior work indicated that
the forces that dictate these phenotypes may very well oper-
ate in an independent fashion. As example, the consensus
palindromic sequence at sites of HIV-1 integration was un-
changed in cells knocked out for expression of the domin-
ant chromatin targeting factor LEDGF/p75 [24,25]. In this
report we have expanded the analysis of local tDNA site de-
terminants across a representative sampling of Retroviridae.
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Figure 6 BRD4 protein and interaction with Rev-A IN. (A) Schematic of human BRD4 isoform C (NCBI reference sequence NP_055114.1) highlighting
various protein domains and the 426–720 fragment used in this study. (B) Ni-NTA pull-down of purified BRD4462–720 by His6-tagged Rev-A IN. Migration
positions of standards (in kDa) are labeled to the left. Lanes 1–4: 20% reaction input of the indicated proteins. Lanes 5 and 6: the indicated BRD4462–720
protein was incubated with Ni-NTA beads in the absence of Rev-A IN. Lanes 7 and 8: the indicated BRD4462–720 protein was incubated with
Rev-A IN-bound beads. The gel is representative of results obtained from three independent experiments.
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integration sites
Dinucleotide flexibility is arguably the most crucial
sequence-dependent determinant of DNA conformation,
with results of numerous studies confirming the specific
role of YR steps in DNA bending [71-74]. Base stacking
interactions play an even greater role in enforcing the
conformation of the DNA double helix than Watson-
Crick base pairing or phosphodiester backbone integrity
[75-78]. Due to their relative lack of base overlap, YR di-
nucleotide steps possess the greatest level of inherent
flexibility of the four purine/pyrimidine dinucleotides
[32]. On the contrary, RY steps share the greatest surface
area (RR and YY steps exhibit intermediate base overlap)
and consequently display significantly lower propensities
for roll, twist, slide, and other DNA bendability charac-
teristics [71-73]. YR steps have accordingly been ob-
served with near 50% frequency at sections of severe
kinking in histone-wrapped DNA, while RY steps are by
far the least represented at about 14% [79]. PFV selects
for YR dinucleotides at the center of its integration sites
[12] (Figure 1E), which facilitates IN-mediated minor
groove compression of tDNA within the TCC to the
point of central base pair unstacking. Our subsequent
observation that central YR dinucleotides are enriched
within HIV-1 integration sites [33] led us to extend the
dinucleotide step analysis of integration sites to 10
additional retroviruses.HIV-1, SIV, MoMLV, and ASLV integration sites were
previously examined for physical properties related to
DNA flexibility including A-philicity, protein-induced
deformability, and bendability [15]. Both A-philicity and
protein-induced deformability are based on dinucleotide
frequencies. While all four sets of integration sites dis-
played similar A-philicity profiles, the protein-induced
deformability profile was less dramatic for ASLV than for
HIV-1, SIV, and MoMLV, which is consistent with the re-
sults reported here. Bendability scores – which are based
on trinucleotide frequencies [80] – were higher for HIV-1
and SIV than for MoMLV or ASLV. By contrast, our find-
ings indicate that tDNA is likely to undergo severe bend-
ing during MoMLV integration. Although this prior work
importantly indicated the general bendable nature of
retroviral integration sites, the YR/RY step analyses per-
formed here pinpoint salient bendable tDNA phospho-
diester bonds that contribute to vDNA integration.
Quantitatively comparing levels of enriched flexibility at
specific tDNA bonds using trinucleotide-based metrics
may prove suboptimal, as only the integration sites of vi-
ruses that yield 5 bp TSDs contain a central trinucleotide.
Furthermore, trinucleotide parameters as relating to bend-
ability were originally deduced by probabilistic modeling
of DNase I digestion data [80], which is a fairly indirect
approach for classifying global levels of bendability for
runs of nucleotides. To this point we tallied the frequency
of all possible trinucleotide combinations falling at the
Figure 7 Concerted integration activity of Rev-A IN. (A) Ethidium bromide stained image of Rev-A IN integration reactions in the presence of
increasing concentrations of indicated BRD4462–720 protein. Migration positions of standards (in kb) are shown to the left, and the positions of
single vDNA end, or half-site, and concerted vDNA integration products, as well as supercoiled (s.c.) and open circular (o.c) forms of the plasmid
tDNA, are to the right. Lanes 1 and 2: Rev-A IN and tDNA incubated without vDNA or with vDNA, respectively. Lanes 3–6: increasing concentrations
(0.05, 0.15, 0.35, 0.5 μM) of BRD4462–720 incubated with Rev-A IN plus vDNA and tDNA. Lanes 7–10: same as lanes 3–6 but with BRD4462–720/L630E.
(B) Strand transfer activities for three independent experiments ± standard error of the mean, measured by quantification of DNA band intensity. The
results were normalized to the level of Rev-A IN concerted integration activity in the absence of BRD4462–720 proteins, which was set to 100%. P values
of <0.05 and <0.01 are indicated by * and **, respectively, as determined by one-tailed t-test.
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that yield 5 bp TSDs (EIAV, HIV-1, Rev-A, and SIV), and
found that A/T-rich trinucleotides (TAA/TTA, ATA/TAT,
and AAA/TTT) were on average preferred by all four vi-
ruses compared to the MRC (Additional file 6: Figure S5).
Because these sequences do not correlate well with DNase
I-based trinucleotide flexibility classification [80], we
propose that DNA bendability as applied to retroviral inte-
gration sites is better judged by YR/RY dinucleotide step
analysis.
Based on the overall similar nature of the YR/RY histo-
grams for the integration sites with 4 bp TSDs (Figure 1),
we conclude that each of these viral intasomes is likelyto accommodate tDNA with a severe central bend, akin
to that observed in the PFV TCC crystal structure [12].
The two PFV IN active sites in the TCC are separated by
approximately 26.3 Å, and the central dinucleotide ac-
crues ~55° in negative roll to unstack the tDNA to pos-
ition scissile phosphodiester bonds that are separated by
4 bp at these two positions [12]. The tDNA bend is con-
siderably more extreme than at any position on nucleo-
somal DNA. A recent structural study revealed ancillary
IN-histone and IN-DNA contacts on the sides of the
tDNA-binding groove of the PFV intasome that help to
lift nucleosomal DNA from the surface of the histone
octamer for productive engagement between the IN
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base preferences in the immediate vicinity of the integra-
tion site is independent of chromatinization (Figures 4
and 5), and also why nucleosomes may dampen the ex-
tent of such preferences (Figure 5).
Our prior work with HIV-1 indicated that the central
positions of these integration sites are also likely to kink
severely [33]. Due to the odd number of intervening bp,
two adjacent tDNA dinucleotide steps seemingly collaborate
to elicit the bend required for HIV-1 integration. While the
other analyzed viruses that yield 5 bp TSDs in general dis-
played similar YR/RY histograms as HIV-1, our findings indi-
cate that in these cases one of two central steps contributes
more significantly to tDNA deformation during integration.
As examples, flexibility at dinucleotide bin position +2 was
significantly more important for SIV integration, whereas
Rev-A selected for flexibility signatures at dinucleotide bin
position +1 (Figure 2E-H). Given the lack of tactile TCC
structures, the reasons for this apparent asymmetry are
unclear and, in the case of SIV, may be a consequence of
the relatively limited number of sites analyzed (Table 1).
Our results indicate that viruses that yield 6 bp TSDs
likely require less flexibility at the center of their integra-
tion sites than do the viruses that cut tDNA with a 4 bp or
5 bp stagger. Why would some retroviruses require less
central flexibility than others? Because phosphodiester
bonds apposed by 6 bp are separated by 20.4 Å in canon-
ical B-form DNA, it seems possible that significantly less
deformation is required to fit chromosomal DNA into the
two active sites of a viral intasome that generates a 6 bp
TSD. The positions of the IN active sites in viral intasomes
that yield 6 bp TSDs could also be further apart than those
observed in PFV TCC structure. Furthermore, the extent
of chromatin compaction can influence IN activity in vitro
[81,82]. Viruses that yield 6 bp TSDs might accordingly
display decreased affinity for nucleosomes, which are rela-
tive hotspots of YR dinucleotide content [68,79]. To assess
if viruses such as ASLV that generate 6 bp TSDs display
evidence for relatively nucleosome-depleted regions of
chromatin during integration, we extended the boundaries
of the tDNA sequence logos to encompass 50 nucleotides
(Additional file 7: Figure S6A-C). Most of the analyzed
integration sites, including those generated by ASLV,
HERV-K, and HTLV-1 (Additional file 7: Figure S6C),
showed evidence for nucleosome content adjacent to
the local regions of TSD. MMTV and PERV by contrast
failed to reveal evidence for periodic A/T-enriched
peaks emanating outward from the integration sites.
Based on this analysis, the ability to integrate into nucleo-
somal arrays does not seem to track with the size of TSD.
We note that a report published after the submission of
this paper indicated that MLV and PFV integration can
occur in regions of compact chromatin that tend to dis-
favor HIV-1 and ASLV integration [45].IN-tDNA interactions during retroviral integration
The modeling of thymidine for the preferred tDNA cyti-
dine at the point of vDNA joining suggested that the me-
thyl group at the C5 position of thymine may clash with
the scissile phosphodiester bond, providing a structural ac-
count for why PFV avoids integration at T residues [12].
As each of the analyzed viruses – with the exception of
MMTV – prominently disfavored insertion at a T residue
(Additional file 1: Figure S1), this aspect of intasome nu-
cleoprotein structure appears nearly universal. We add-
itionally observed a symmetric preference for thymidine/
adenosine at either two or three bases exterior to the TSD
boundary across the majority of integration sites (Figures 1,
2 and 3, A-D). Through mutagenesis experiments we pre-
viously revealed that HIV-1 IN residue Ser119, which is
structurally analogous to PFV IN residue Ala188, helps to
determine the identity of tDNA bases three positions up-
stream from the points of vDNA insertion [33]. Neutral,
compact amino acids occupy the analogous position of the
CCD α2 helix across retroviruses (Additional file 8: Figure
S7), and correlating these residues with tDNA sequence
preferences suggests that the polarity of the amino acid
side chain dictates IN-tDNA interactions. Specifically,
non-polar residues alanine and proline dictate preference
for thymidine/adenosine at two bases upstream/down-
stream of the vDNA insertion sites regardless of TSD
length, while polar amino acids serine and threonine shift
this preference one base further outward from the tDNA
cut, to three bases upstream/downstream. Scrutiny of
the corresponding YR/RY peaks reinforces that al-
though serine and threonine dictate the T/A preference
at the same relative tDNA position, the specifics of the
nucleoprotein contacts are not identical. Serine yields
the T/A preference at positions −3/+7 for HIV-1, while
the S119T IN mutation [33] as well as the threonine
that is naturally present in EIAV IN, switches this pref-
erence to A/T (Figure 2). Recent studies have deter-
mined integration sites of HIV-1 IN mutants that
harbor all possible small amino acid substitutions for
Ser119 in the CCD (S119A, S119T, S119P, S119G)
[33,83]. Consistent with our observations, Ser119 as
well as the Thr substituent were modeled to interact
with bases at tDNA positions −3/+7 while Ala and Gly
were modeled to interact with positions −2/+6 [83].
Rev-A integration distribution and BET proteins
Our results reveal that Rev-A shares similar integration
site distribution patterns with other gammaretroviruses
(Table 2). Of the four gammaretroviruses analyzed in this
study, the targeting of chromatin-specific features was
most similar between Rev-A and MoMLV (Table 2 and
Additional file 5: Figure S4). Purified BRD4462–730 inter-
acted with Rev-A IN and stimulated its concerted integra-
tion activity, and the L630E amino acid substitution in
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(Figures 6 and 7). Rev-A and MoMLV are thus likely di-
rected to integrate into signature chromatin features using
similar BET protein-IN mediated interactions. The unique
chromatin targeting preferences of PERV and XMRV sug-
gest that these viruses may interact with additional host
factors to guide promoter-proximal integration events.
Conclusions
The work presented here clarifies that conserved palin-
dromic sequences at sites of retroviral DNA integration
reflect the requirement for a central tDNA bend and
that the sharpness of the required deformation is re-
duced for viruses that generate 6 bp TSDs. It seems
plausible that retroviruses have convergently evolved to
select not necessarily a specific sequence of nucleotides
at integration sites, but rather combinations of bases
that yield a flexibility pattern that is favorable for tDNA
incorporation into the TCC. Retroviral base preferences
and associated flexibility profiles appear largely inde-
pendent of tDNA chromatinization, suggesting that IN
interactions with tDNA nucleotides dictate integration
site selection on the local scale.
Methods
Plasmids, cell culture, and virus infection
A human BRD4 expression construct was purchased from
Addgene (plasmid #14441). The region of BRD4 corre-
sponding to amino acids 462–720 was PCR-amplified using
primers AE5271 (5′-GATATACCCGGGGAGGAGCCAG
TGGTGGCCGTG) and AE5270 (5′-GCAGCACTCGAG
TTACTCTGTTTCGGAGTCTTC). The PCR product was
cleaved with XhoI and XmaI, and ligated to XhoI/XmaI-
digested pCPH6P [84]. The L630E amino acid substitution
was introduced by site-directed mutagenesis (Stratagene
QuickChange II kit) using primers AE5362 (5′-AAGCTCC
CCGGCGAGAAGGAGGGCCGCGTGGTGCACATC)
and AE5363 (5′-GATGTGCACCACGCGGCCCTCCTTC
TCGCCGGGGAGCTT). Plasmids pCPH6P-RevA-IN [66],
pJD215 [85], pSW253 [86], and pCG-VSV-G [25] were pre-
viously described.
HEK293T and HeLa cells were cultured in Dulbecco’s
Modified Eagle Media supplemented to contain 10%
fetal bovine serum, 100 IU/mL penicillin, and 100 μg/
mL streptomycin. HEK293T cells were transfected with
pJD215, pSW253, and pCG-VSV-G at the ratio of
4.5:4.5:1 using PolyJet (SignaGen). After 48 h, the cell-
free supernatant was filtered through 0.45 μm filters,
concentrated by ultracentrifugation at 200,000 g for 1 h,
and treated with 40 U/mL DNase Turbo (Ambion). Viral
titer was determined by infecting 3 x 105 HeLa cells with
two-fold dilutions of virus in the presence of 500 μg/mL
G418 (Life Technologies) and counting neomycin-
resistant colony forming units after 7 d. For integrationsite sequencing, HEK293T cells (5 x 106) were infected
and treated similarly for 7 d to select for transductants
and to allow for dissolution of unintegrated vDNA.
Expression and purification of recombinant proteins
His6-tagged Rev-A IN was expressed in Escherichia coli
and purified essentially as previously described [66], but
without hexahistidine tag cleavage. BRD4462–720 and
BRD4462–720/L630E were expressed in E. coli strain PC2
[84] by overnight induction with 1 mM isopropyl-β-D-
thiogalactopyranoside at 18°C. The bacterial pellets were
dissolved in 50 mM Tris HCl, pH 7.5, 500 mM NaCl,
and 1 mM phenylmethanesulfonylfluoride, lysed by son-
ication, and clarified by centrifugation at 40,000 g for 1
h. BRD4462–720 and BRD4462–720/L630E were bound to a
HisTrap HP column and eluted using a 20–500 mM
imidazole gradient on an AKTA purifier liquid chroma-
tography system (GE Healthcare). Fractions containing
the protein of interest were pooled together and quickly
diluted 5-fold with 50 mM Tris HCl, pH 7.5 to reduce
the concentration of NaCl to 100 mM and then loaded
on a HiTrap Heparin column and eluted with a 100–
1000 mM NaCl gradient. Finally, the proteins were puri-
fied by gel filtration using a Superdex 200 column in 50
mM Tris HCl, pH 7.5, 500 mM NaCl, 2 mM dithiothrei-
tol (DTT). Chromatography columns were purchased
from GE Healthcare.
Pull-down assay
For in vitro Ni-NTA pull-down assays, 10 μg of His6-
tagged Rev-A IN in 100 μL pull-down buffer (25 mM Tris
HCl pH 7.5, 150 mM NaCl, 25 μM ZnCl2, 0.1% (v/v) Noni-
det P40, 20 mM imidazole) was mixed with 10 μL settled
volume of Ni-NTA beads (Thermo Scientific) previously
washed with pull-down buffer. Following incubation at 4°C
for 2 h with gentle agitation, 10 μg BSA and 10 μg of
BRD4462–720 or BRD4462–720/L630E were added, and mix-
tures were incubated overnight at 4°C. The beads were
washed five times with pull-down buffer and briefly centri-
fuged for 1 min at 1,300 g, and were then resuspended
in 20 μL 2X sodium dodecyl sulfate (SDS) gel loading
buffer and boiled for 10 min. The resulting supernatant
was analyzed by denaturing gel electrophoresis on a
10% acrylamide gel. Proteins were detected by staining
with Coomassie blue.
DNA strand transfer activity assay
The in vitro concerted integration assays were carried out
as previously for described Rev-A IN following removal of
the His6-tag by site-specific proteolysis [66]. Briefly, 1 μM
Rev-A IN mixed with 0.5 μM vDNA and 4 nM pGEM-3
tDNA, in 40 μL of 20 mM HEPES pH 7.4, 50 mM NaCl, 5
mM MgCl2, 4 μM ZnCl2, and 10 mM DTT, was incubated
for 1 h at 37°C with varying concentrations of BRD4462–720
Serrao et al. Retrovirology  (2015) 12:39 Page 15 of 18or BRD4462–720/L630E (0.05/0.15/0.35/0.5 μM). Reactions
were stopped by adding 25 mM EDTA and 0.5% SDS, and
deproteinized by digestion with proteinase K. Products
were precipitated with ethanol and analyzed by electro-
phoresis through 1.5% agarose gels. DNA was detected by
staining with ethidium bromide. Concerted integration
products were measured by band intensity quantification
using the Molecular Imager® Gel Doc TM XR+ System
with Image Lab software (Bio-Rad).
Sequencing of Rev-A integration sites
Genomic DNA (20 μg) isolated using the DNeasy Blood
and Tissue Kit (Qiagen) was digested overnight with
AvrII, NheI, and SpeI and purified using the QIAquick
PCR Purification Kit (Qiagen). A double-stranded asym-
metric linker was prepared by annealing 10 μM of oligo-
nucleotides AE5237 (5′-[Phosp]CTAGGCAGCCCG[Am
C7-Q]-3′) and AE5238 (GTAATACGACTCACTATAG
GGCACGCGTGGTCGACGGCCCGGGCTGC) by heating
to 90°C in 10 mM Tris–HCl, pH 8.0 and 0.1 mM EDTA
and slowly cooling to room temperature. Linker DNA
(1.5 μM) was ligated with digested cellular DNA (1 μg)
overnight at 16°C in four parallel reactions, and the
DNAs were pooled and re-purified using the QIAquick
PCR Purification Kit. Nested PCR was used to selectively
amplify integration sites, with reactions multiplexed into
eight separate samples per PCR stage. First- and second-
round linker primers were AE5240 (5′-GACTCACTATA
GGGCACGCGT) and AE5242 (5′-GTCGACGGCCCGG
GCTGCCTA), and first- and second round Rev-A U5
primers were AE6121 (5′-GCAGGGATCCGGACTG) and
AE6122 (5′-CCGTAGTACTTCGGTACAAC), respectively.
PCRs were incubated at 94°C for 2 min, followed by 30 cy-
cles at 94°C for 15 sec, 55°C for 30 sec, and 68°C for 45 sec,
which was followed by a final extension for 10 min at 68°C.
Pooled PCRs were purified using the QIAquick PCR Purifi-
cation Kit, and standard Illumina adapters were ligated
onto the amplicons prior to sequencing on the Illumina
MiSeq platform at the Data-Farber Cancer Institute Mo-
lecular Biology Core Facilities. Sequences were mapped to
hg19 version of human genome using BLAT, ensuring that
the genomic match starts immediately after TACTTCGG-
TACAACA sequence, which corresponds to the processed
Rev-A U5 end. Bioinformatics analysis of Rev-A integration
sites was performed as described previously [87].
Statistical analysis
An MRC dataset of 282,824 sites was created by select-
ing random genomic positions in proximity (<500 bp) of
a AvrII, NheI or SpeI recognition site. The sequence im-
mediately abutting each random site, truncated to 97 bp
or less (to simulate Illumina read length), was subjected
to the genomic alignment procedure described above.
Differences in nucleotide sequence from random amongretroviral integration sites were determined by chi-
square analysis relative to the above random control.
Statistical differences with respect to YR/RY frequency
plots and genomic distribution of integration sites was
calculated by Fisher’s Exact Test using R [88].
Additional files
Additional file 1: Figure S1. Nucleotide preferences at tDNA base
positions surrounding retroviral integration sites. The number in parentheses
indicates the number of unique integration sites analyzed for each
virus. Chi-square analysis was used to calculate P values by comparing
observed nucleotide frequencies to the expected frequency based on
282,824 random points in the human genome. Significant differences
are marked by blue shade and bold character (P < 0.05). Nucleotide
frequencies that differed from the neutral value of 100% by more than
40 are highlighted in red (<60%) and green (>140%).
Additional file 2: Figure S2. Statistical analysis of YR/RY dinucleotide
frequencies across retroviral integration sites. (A and B) P values calculated by
Fisher’s Exact Test for statistical comparison of YR and RY dinucleotide
frequency profiles as compared to the MRC of 282,824 randomly-generated
sites for viruses that yield 4 bp TSDs. (C and D) Statistical analysis of
dinucleotide frequencies for viruses that yield 5 bp TSDs. (E and F)
Analysis of dinucleotide frequency statistics for viruses with 6 bp TSDs.
The dotted gray horizontal line in all panels demarcates the statistical
cutoff value of 1.3 (−log10(0.05)). Curve flattening results from the statistical
cutoff of 2.2 × 10−308 of the utilized statistical package [88]. Asterisks denote
curves graphed on the secondary y-axis to the right of the charts.
Additional file 3: Table S1. P values for comparison of retroviral
integration site distributions versus MRC. Values > 0.05 are highlighted in
bold italics.
Additional file 4: Figure S3. P values for comparison of PFV integration
site distribution in deproteinized tDNA and from virus-infected cells to
the MRC dataset. Counts of integration sites within RefSeq genes and
relative to CpG islands and TSSs, as well as regional gene densities, are
listed in Table 2.
Additional file 5: Figure S4. P values for comparison of Rev-A integration
site distribution to other gammaretroviruses, HIV-1, PFV, and to the
MRC dataset. Numbers of integration sites within RefSeq genes and
nearby CpG islands and TSSs, as well as regional gene density profiles,
are listed in Table 2.
Additional file 6: Figure S5. Trinucleotide frequencies at centers of 5
bp TSDs. The frequency of all possible trinucleotides residing at the
central three bases of EIAV, HIV-1, Rev-A, and SIV integration sites was
computed and compared to the random distribution given by the MRC
dataset. Y-axis values represent the percent increase in usage over random.
The x-axis displays the most frequently-utilized trinucleotides arranged from
left to right.
Additional file 7: Figure S6. Extended sequence logos depicting base
preferences at a total of 50 bases surrounding retroviral integration sites.
The Y-axis scales were set to 0.2 bits for all logos in order to highlight T/A
periodicity, and thus some of the overly prominent base preferences at the
centers of the integration sites are slightly obscured. (A) Sequence logos for
viruses that yield 4 bp TSDs are compared to the average sequence of chicken
erythrocyte nucleosomal DNA and to the in vitro dataset of recombinant PFV
integration sites. (B) Same as in panel A, except the analyzed viruses generate
5 bp TSDs. The in vitro HIV-1 integration dataset is from ref. [33]. (C) Extended
sequence logos for viruses that yield 6 bp TSDs, compared to the average
nucleosome content of chicken DNA.
Additional file 8: Figure S7. Amino acid sequence alignment of CCD
α2 helix residues for the viruses analyzed in this study. The location of
secondary structural elements has been documented crystallographically
for HIV-1 [89], ASLV [90], SIV [91], and PFV [2] INs. Residues analogous to
Ala188 in PFV and Ser119 in HIV-1 INs are highlighted in yellow. The
active site residue that is analogous to Asp185 in PFV IN and Asp116 in
HIV-1 IN is in red type.
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